Covered recipient · General Payments record
PRAVALLIKA CHADALAVADA
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$2,039.57
- Reported across 93 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $434.71 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $292.06 | 13 |
| Janssen Biotech, Inc. | $66.02 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $58.53 | 2 |
| Lilly USA, LLC | $18.10 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.95 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103433876 | CMS |
| ABBVIE INC. | $21.11 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103433878 | CMS |
| ABBVIE INC. | $20.62 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103433880 | CMS |
| ABBVIE INC. | $20.91 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103433882 | CMS |
| ABBVIE INC. | $15.81 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103433884 | CMS |
| ABBVIE INC. | $1.70 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103433886 | CMS |
| ABBVIE INC. | $20.76 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103433888 | CMS |
| ABBVIE INC. | $87.95 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103433890 | CMS |
| ABBVIE INC. | $22.12 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103433892 | CMS |
| ABBVIE INC. | $16.54 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103433894 | CMS |
| ABBVIE INC. | $1.24 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103433896 | CMS |
| ABBVIE INC. | $20.74 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103433898 | CMS |
| ABBVIE INC. | $20.61 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103433900 | CMS |
| Janssen Biotech, Inc. | $21.05 | 02/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078784100 | CMS |
| Janssen Biotech, Inc. | $26.00 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078783911 | CMS |
| Janssen Biotech, Inc. | $18.97 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078783895 | CMS |
| Lilly USA, LLC | $18.10 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135291585 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $35.43 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137505808 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $23.10 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137505811 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.